*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
This half day program will open with a keynote address from Dr. David Stephens, Vice President of Research for the Woodruff Health Sciences Center of Emory University and Principal Investigator of the Atlanta Clinical & Translational Science Institute (ACTSI), focusing on an overview of challenges involving clinical studies. The keynote will be followed by two panel sessions; the first exploring the use of biomarkers to identify patient populations before clinical trials begin, and the second, employing advances in data management to assess outcomes of clinical trials.
OTHER SPEAKERS:
• Mark Braunstein, MD, Associate Director, Health Systems Institute, Georgia Tech
• Scott Capps, Vice President Clinical Research, CryoLife
• Albert E. Heacox, Ph.D. Senior Vice President, Research and Development, CryoLife
• Joseph E. Martinez, Director of Research and Laboratory Services, FlowApps
• Robert T. McNally, Ph.D., President & CEO, Geovax, Inc.
• Ruth O' Regan, MD Director, Translational Breast Cancer Research, The Emory Clinic
• Joel Saltz, M.D., Ph.D., Director, Center for Comprehensive Informatics, Emory University
• Sandy Weinberg, Ph.D., Associate Professor of Healthcare Management, Clayton State University
The program will conclude with an Open Discussion moderated byMargaret K. Offermann, MD, Ph.D., Vice President-Elect for Science Policy, Federation of American Societies for Experimental Biology & Treasurer, Georgia Center for Oncology Research & Education.
A networking reception will end the day.
